- Home
- WRN vs VOR Comparison
WRN vs VOR Comparison
Compare WRN & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.33
HOLD
Current Price
$16.08
Company Overview
Basic Information| Metric | WRN | VOR |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 676.9M | 562.6M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WRN | VOR |
|---|---|---|
| Price | $3.33 | $16.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $4.88 | ★ $64.78 |
| AVG Volume (30 Days) | ★ 2.0M | 694.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $0.13 |
| 52 Week High | $4.26 | $49.95 |
Technical Indicators
Market Signals| Indicator | WRN | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 60.79 |
| Support Level | $2.95 | $11.27 |
| Resistance Level | $4.26 | $16.80 |
| Average True Range (ATR) | 0.20 | 1.21 |
| MACD | 0.01 | 0.29 |
| Stochastic Oscillator | 69.83 | 72.77 |
Price Performance
Historical Comparison WRN
VOR
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.